Pharmacolog carries out rights issue and increases focus on business development
Pharmacolog carries out rights issue with the aim of raising capital for, among other things, continued geographical expansion and production of its own consumables. In addition, the company will reallocate existing resources with the aim of accelerating volume growth via new and existing strategic partners.The board of Pharmacolog i Uppsala AB decided on 5/9 on a preferential issue of units consisting of shares of series B and warrants of series TO2 for approximately SEK 19.2 million. The net proceeds from the Rights Issue are intended, among other things, to be used for increased market